Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis-Reference-Cited by-同舟云学术

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis

Published:2017-01-26 Issue:1 Volume:16 Page:77-89
ISSN:1723-8617
Container-title:World Psychiatry
language:en
Short-container-title:World Psychiatry

Author:

Galling Britta¹²³,Roldán Alexandra⁴,Hagi Katsuhiko²⁵,Rietschel Liz⁶,Walyzada Frozan²,Zheng Wei⁷,Cao Xiao-Lan⁸,Xiang Yu-Tao⁹,Zink Mathias¹⁰,Kane John M.²³¹¹¹²,Nielsen Jimmi¹³¹⁴,Leucht Stefan¹⁵,Correll Christoph U.²³¹¹¹²

Affiliation:

1. Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Charité-Universitätsmedizin Berlin; Berlin Germany

2. Zucker Hillside Hospital, Psychiatry Research, Northwell Health; Glen Oaks NY USA

3. Hofstra Northwell School of Medicine; Hempstead; NY USA

4. Department of Psychiatry; Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona; Barcelona Spain

5. Sumitomo Dainippon Pharma Co.; Tokyo Japan

6. University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern; Bern Switzerland

7. Guangzhou Brain Hospital, Affiliated Hospital of Guangzhou Medical University; Guangzhou China

8. Department of Psychiatry; Chinese University of Hong Kong; Hong Kong SAR China

9. Unit of Psychiatry, Faculty of Health Sciences, University of Macao; Taipa, Macao SAR China

10. Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University; Mannheim Germany

11. Feinstein Institute for Medical Research; Manhasset NY USA

12. Albert Einstein College of Medicine; Bronx; NY USA

13. Department of Psychiatry; Aalborg University Hospital; Aalborg Denmark

14. Department of Clinical Medicine; Aalborg University; Aalborg Denmark

15. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München; Munich Germany

Funder

National Institute of Mental Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Pshychiatric Mental Health

Reference85 articles.

1. One hundred years of schizophrenia: a meta-analysis of the outcome literature;Hegarty;Am J Psychiatry,1994

2. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1);Jones;Arch Gen Psychiatry,2006

3. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia;Lieberman;N Engl J Med,2005

4. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder;Robinson;Am J Psychiatry,2004

5. A systematic review and meta-analysis of recovery in schizophrenia;Jääskeläinen;Schizophr Bull,2013

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data;Schizophrenia Research;2024-10

2. Characterising the nature of psychiatric disorders and patterns of antipsychotic medications prescribed in a psychiatric ward in a public hospital in Tasmania;Australasian Psychiatry;2024-09-13

3. Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review;Expert Opinion on Drug Safety;2024-09-03

4. Prevalence of polypharmacy and factors impacting psychotropic prescribing patterns in women of childbearing potential at inpatient mental health services in Qatar;Neuropsychopharmacology Reports;2024-08-20

5. Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study;Journal of Pharmaceutical Policy and Practice;2024-08-06